Fig. 5.
![Fig. 5. Effects of CrmA overexpression on the susceptibility of Jurkat cells to tumor-mediated apoptosis. / CrmA or control Neo-Jurkat cells were labeled with [3H]TdR and coincubated with tumor cells at a tumor-to-lymphocyte cell ratio of 40:1. As controls, these cells were treated with agonistic anti-Fas Ab (CH-11, 200 ng/mL) or VP-16 (20 μmol/L). Target cell death was determined at the indicated time points by measuring loss in 3H-labeled DNA. The error bars represent the SEM of 8 replicates.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/95/6/10.1182_blood.v95.6.2015/6/bloo00630005x.jpeg?Expires=1735571587&Signature=H74ZRIv5PkUahHAy2opwZ8A0WkglbpzS7wsZFAnqeGmCP5vxZFanevkPNeQPYGs5c6H24Mcwk~SgeI48hardki8URteWJULkDvyAnDpPvTFDNvi~1NbQmFZ2oOOFZUukzHkZ18kz0alA2xjWQxx1LIHvGNfYH6Fvl3NZ1P32EnTqjv0uhNSO1VWujJPDHfj2L1ZjtaRhazo0ULEAqVfKx7aOOLno7IBR9V5tSe4Z7GnIRavKHIHV~hqRIQOIUvANAqPdoI9jWXsF5CNf~X06QeUrRn1psKJEdvTbKcDzYkpS~8ifxevkIvqzBsOfXISa9MzaSoWEpxUacO0X4QgeCA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effects of CrmA overexpression on the susceptibility of Jurkat cells to tumor-mediated apoptosis.
CrmA or control Neo-Jurkat cells were labeled with [3H]TdR and coincubated with tumor cells at a tumor-to-lymphocyte cell ratio of 40:1. As controls, these cells were treated with agonistic anti-Fas Ab (CH-11, 200 ng/mL) or VP-16 (20 μmol/L). Target cell death was determined at the indicated time points by measuring loss in 3H-labeled DNA. The error bars represent the SEM of 8 replicates.
